Abstract |
A 78-year-old male with sigmoid colon cancer underwent sigmoidectomy. The lesion was se, p1(+), n1, and Stage IV. Oral UFT therapy was performed, but was replaced with oral S-1 therapy 1 year and 6 months after surgery. Three months later, lung metastases 2.0 x 1.5 cm and 0.6 x 0.6 cm were found by chest CT in right S10a and S5b, respectively. Since the patient did not wish surgery, the treatment was changed to oral UFT/ Leucovorin(LV) therapy(UFT 300 mg/ LV 75 mg, 4-week administration and 1-week no-administration periods). After 2 courses, chest CT showed disappearance of both lung metastases, indicating complete remission. Oral UFT/LV therapy is convenient because of the oral route. Adverse reactions are few, and the therapeutic effect has been reported to be comparable to that of intravenous 5-FU/LV therapy. Also, in this patient, no adverse reaction was noted, and complete remission was maintained until the patient died of another disease 31 months after the beginning of oral UFT/LV therapy.
|
Authors | Mikio Okamura, You Kamiizumi, Norio Kawamura, Ryoji Yokoyama, Koji Itoh, Kenji Abe, Yasuaki Nakajima |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 35
Issue 7
Pg. 1205-7
(Jul 2008)
ISSN: 0385-0684 [Print] Japan |
PMID | 18633264
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Tegafur
- Uracil
- Leucovorin
|
Topics |
- Administration, Oral
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, therapeutic use)
- Colonic Neoplasms
(diagnostic imaging, drug therapy, pathology, surgery)
- Humans
- Leucovorin
(administration & dosage, therapeutic use)
- Lung Neoplasms
(diagnostic imaging, drug therapy, secondary)
- Male
- Radiography
- Tegafur
(administration & dosage, therapeutic use)
- Uracil
(administration & dosage, therapeutic use)
|